CURE’s bladder cancer page is a go-to resource for oncology news and updates in the world of bladder cancer. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in bladder cancer.
May 24th 2024
The FDA has approved several treatments for patients with solid tumors. Here are five recently approved treatments.
Phase 3 Interim Analysis Shows Improved Survival in Patients with Bladder Cancer
January 7th 2020Patients with previously untreated locally advanced or metastatic urothelial carcinoma treated with Bavencio and best supportive care as a first-line maintenance therapy experienced significantly longer survival.
FDA Grants Priority Review to Keytruda for Non-Muscle Invasive Bladder Cancer
December 3rd 2019The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Keytruda (pembrolizumab), an anti-PD-1 immunotherapy, for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC), according to Merck, the drug’s manufacturer.
New Targeted Antibody Shows Promise for Advanced Urothelial Cancer
June 3rd 2019After progressing on prior therapy, 44% of patients with locally advanced or metastatic urothelial cancer who were treated with enfortumab vedotin demonstrated a response to treatment, according to phase 2 study findings.
Non-Invasive Urine Tests Show Promise in Bladder Cancer Detection, Monitoring
May 17th 2019With no available diagnostic tests for the detection and/or monitoring of bladder cancer, researchers from the Medical College of Georgia at Augusta University may have two new urine tests that determine the disease’s severity and detect for its recurrence.
Smoking Cessation Programs Help Reduce Bladder Cancer Risk in Older Women
May 15th 2019A recent study showed that postmenopausal women demonstrated a significant reduction in the risk for bladder cancer after quitting smoking, highlighting the need for prevention and cessation programs in older women.
FDA Approves First Targeted Therapy to Treat Metastatic Bladder Cancer
April 12th 2019The Food and Drug Administration granted accelerated approval to Balversa to treat locally advanced or metastatic bladder cancer with a type of susceptible genetic alterations known as FGFR3 or FGFR2, in patients who have progressed during or following prior platinum-containing chemotherapy.